MPT WWW
Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.

Commentary

"Hollywood" Extortion
Robert Goldberg, Ph.D., Washington Times, 10-5-04

Dr. Goldberg writes about Irena Medavoy's suit alleging that she was harmed by the use of Botox to relieve her migraines. At issue here is the ability of physicians to use approved drugs for non-approved purposes, called "off-label" use. He notes that off-label use is widespread and leads to many medical advances, as the FDA and private industry could not possibly test for every possible use of a drug before putting into the market. Finding a drug manufacturer and physician liable for off-label use would set back medical progress.


Project FDA.
  
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org